These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12592337

  • 1. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
    Pettiford SM, Herbst R.
    Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
    [Abstract] [Full Text] [Related]

  • 2. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
    Pettiford SM, Herbst R.
    Oncogene; 2000 Feb 17; 19(7):858-69. PubMed ID: 10702794
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Kim KW, Kim SH, Lee EY, Kim ND, Kang HS, Kim HD, Chung BS, Kang CD.
    J Biol Chem; 2001 Apr 20; 276(16):13186-91. PubMed ID: 11278385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
    Lee CH, Yun HJ, Kang HS, Kim HD.
    IUBMB Life; 1999 Dec 20; 48(6):585-91. PubMed ID: 10683762
    [Abstract] [Full Text] [Related]

  • 7. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
    Herrera R, Hubbell S, Decker S, Petruzzelli L.
    Exp Cell Res; 1998 Feb 01; 238(2):407-14. PubMed ID: 9473349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
    Mustelin T, Tautz L, Page R.
    J Mol Biol; 2005 Nov 18; 354(1):150-63. PubMed ID: 16226275
    [Abstract] [Full Text] [Related]

  • 11. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.
    Gronda M, Arab S, Iafrate B, Suzuki H, Zanke BW.
    Mol Cell Biol; 2001 Oct 18; 21(20):6851-8. PubMed ID: 11564869
    [Abstract] [Full Text] [Related]

  • 12. ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells.
    Chaman N, Iqbal MA, Siddiqui FA, Gopinath P, Bamezai RN.
    J Biol Chem; 2015 Sep 25; 290(39):23803-15. PubMed ID: 26269597
    [Abstract] [Full Text] [Related]

  • 13. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH, Ha KT, Kim KW, Chang YC, Lee YC, Ko JH, Kim CH.
    Biochim Biophys Acta; 2008 May 25; 1780(5):757-63. PubMed ID: 18339327
    [Abstract] [Full Text] [Related]

  • 14. Megakaryocytic differentiation of K562 cells is associated with changes in the cytoskeletal organization and the pattern of chromatographically distinct forms of phosphotyrosyl-specific protein phosphatases.
    Bütler TM, Ziemiecki A, Friis RR.
    Cancer Res; 1990 Oct 01; 50(19):6323-9. PubMed ID: 2169344
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [Abstract] [Full Text] [Related]

  • 16. Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T-cells: dynamics and subcellular location.
    Nika K, Hyunh H, Williams S, Paul S, Bottini N, Taskén K, Lombroso PJ, Mustelin T.
    Biochem J; 2004 Mar 01; 378(Pt 2):335-42. PubMed ID: 14613483
    [Abstract] [Full Text] [Related]

  • 17. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
    Bártová E, Harnicarová A, Pacherník J, Kozubek S.
    Leuk Res; 2005 Aug 01; 29(8):901-13. PubMed ID: 15978941
    [Abstract] [Full Text] [Related]

  • 18. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
    Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B.
    Cell Death Differ; 2009 Jan 01; 16(1):164-74. PubMed ID: 18820643
    [Abstract] [Full Text] [Related]

  • 19. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
    Niitsu N, Yamamoto-Yamaguchi Y, Miyoshi H, Shimizu K, Ohki M, Umeda M, Honma Y.
    Cell Growth Differ; 1997 Mar 01; 8(3):319-26. PubMed ID: 9056674
    [Abstract] [Full Text] [Related]

  • 20. Signaling mechanism of PMA-induced differentiation of K562 cells.
    Kang CD, Lee BK, Kim KW, Kim CM, Kim SH, Chung BS.
    Biochem Biophys Res Commun; 1996 Apr 05; 221(1):95-100. PubMed ID: 8660351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.